Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma

<p>Abstract</p> <p>Background</p> <p>The response to β<sub>2</sub>-adrenoceptor agonists is reduced in asthmatic airways. This desensitization may be in part due to inflammatory mediators and may involve cysteinyl-leukotrienes (cysteinyl-LTs). Cysteinyl-LTs...

Full description

Bibliographic Details
Main Authors: Milanese Manlio, Ravasi Saula, Brichetto Lorenzo, Citro Simona, Baroffio Michele, Rovati G Enrico, Crimi Emanuele, Brusasco Vito
Format: Article
Language:English
Published: BMC 2006-07-01
Series:Respiratory Research
Online Access:http://respiratory-research.com/content/7/1/103
_version_ 1818327586275590144
author Milanese Manlio
Ravasi Saula
Brichetto Lorenzo
Citro Simona
Baroffio Michele
Rovati G Enrico
Crimi Emanuele
Brusasco Vito
author_facet Milanese Manlio
Ravasi Saula
Brichetto Lorenzo
Citro Simona
Baroffio Michele
Rovati G Enrico
Crimi Emanuele
Brusasco Vito
author_sort Milanese Manlio
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The response to β<sub>2</sub>-adrenoceptor agonists is reduced in asthmatic airways. This desensitization may be in part due to inflammatory mediators and may involve cysteinyl-leukotrienes (cysteinyl-LTs). Cysteinyl-LTs are pivotal inflammatory mediators that play important roles in the pathophysiology of asthma, allergic rhinitis, and other inflammatory conditions. We tested the hypothesis that leukotriene D<sub>4 </sub>(LTD<sub>4</sub>) and allergen challenge cause β<sub>2</sub>-adrenoceptor desensitization through the activation of protein kinase C (PKC).</p> <p>Methods</p> <p>The isoproterenol-induced cAMP accumulation was evaluated in human airway smooth muscle cell cultures challenged with exogenous LTD<sub>4 </sub>or the PKC activator phorbol-12-myristate-13-acetate with or without pretreatments with the PKC inhibitor GF109203X or the CysLT<sub>1</sub>R antagonist montelukast. The relaxant response to salbutamol was studied in passively sensitized human bronchial rings challenged with allergen in physiological salt solution (PSS) alone, or in the presence of either montelukast or GF109203X.</p> <p>Results</p> <p>In cell cultures, both LTD<sub>4 </sub>and phorbol-12-myristate-13-acetate caused significant reductions of maximal isoproterenol-induced cAMP accumulation, which were fully prevented by montelukast and GF109203X, respectively. More importantly, GF109203X also prevented the attenuating effect of LTD<sub>4 </sub>on isoproterenol-induced cAMP accumulation. In bronchial rings, both montelukast and GF109203X prevented the rightward displacement of the concentration-response curves to salbutamol induced by allergen challenge.</p> <p>Conclusion</p> <p>LTD<sub>4 </sub>induces β<sub>2</sub>-adrenoceptor desensitization in human airway smooth muscle cells, which is mediated through the activation of PKC. Allergen exposure of sensitized human bronchi may also cause a β<sub>2</sub>-adrenoceptor desensitization through the involvement of the CysLT<sub>1</sub>R-PKC pathway.</p>
first_indexed 2024-12-13T12:18:37Z
format Article
id doaj.art-420f55f0e7c245f9b3b9685238897ba7
institution Directory Open Access Journal
issn 1465-9921
language English
last_indexed 2024-12-13T12:18:37Z
publishDate 2006-07-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-420f55f0e7c245f9b3b9685238897ba72022-12-21T23:46:39ZengBMCRespiratory Research1465-99212006-07-017110310.1186/1465-9921-7-103Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthmaMilanese ManlioRavasi SaulaBrichetto LorenzoCitro SimonaBaroffio MicheleRovati G EnricoCrimi EmanueleBrusasco Vito<p>Abstract</p> <p>Background</p> <p>The response to β<sub>2</sub>-adrenoceptor agonists is reduced in asthmatic airways. This desensitization may be in part due to inflammatory mediators and may involve cysteinyl-leukotrienes (cysteinyl-LTs). Cysteinyl-LTs are pivotal inflammatory mediators that play important roles in the pathophysiology of asthma, allergic rhinitis, and other inflammatory conditions. We tested the hypothesis that leukotriene D<sub>4 </sub>(LTD<sub>4</sub>) and allergen challenge cause β<sub>2</sub>-adrenoceptor desensitization through the activation of protein kinase C (PKC).</p> <p>Methods</p> <p>The isoproterenol-induced cAMP accumulation was evaluated in human airway smooth muscle cell cultures challenged with exogenous LTD<sub>4 </sub>or the PKC activator phorbol-12-myristate-13-acetate with or without pretreatments with the PKC inhibitor GF109203X or the CysLT<sub>1</sub>R antagonist montelukast. The relaxant response to salbutamol was studied in passively sensitized human bronchial rings challenged with allergen in physiological salt solution (PSS) alone, or in the presence of either montelukast or GF109203X.</p> <p>Results</p> <p>In cell cultures, both LTD<sub>4 </sub>and phorbol-12-myristate-13-acetate caused significant reductions of maximal isoproterenol-induced cAMP accumulation, which were fully prevented by montelukast and GF109203X, respectively. More importantly, GF109203X also prevented the attenuating effect of LTD<sub>4 </sub>on isoproterenol-induced cAMP accumulation. In bronchial rings, both montelukast and GF109203X prevented the rightward displacement of the concentration-response curves to salbutamol induced by allergen challenge.</p> <p>Conclusion</p> <p>LTD<sub>4 </sub>induces β<sub>2</sub>-adrenoceptor desensitization in human airway smooth muscle cells, which is mediated through the activation of PKC. Allergen exposure of sensitized human bronchi may also cause a β<sub>2</sub>-adrenoceptor desensitization through the involvement of the CysLT<sub>1</sub>R-PKC pathway.</p>http://respiratory-research.com/content/7/1/103
spellingShingle Milanese Manlio
Ravasi Saula
Brichetto Lorenzo
Citro Simona
Baroffio Michele
Rovati G Enrico
Crimi Emanuele
Brusasco Vito
Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma
Respiratory Research
title Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma
title_full Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma
title_fullStr Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma
title_full_unstemmed Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma
title_short Cysteinyl-leukotrienes in the regulation of β<sub>2</sub>-adrenoceptor function: an in vitro model of asthma
title_sort cysteinyl leukotrienes in the regulation of β sub 2 sub adrenoceptor function an in vitro model of asthma
url http://respiratory-research.com/content/7/1/103
work_keys_str_mv AT milanesemanlio cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma
AT ravasisaula cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma
AT brichettolorenzo cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma
AT citrosimona cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma
AT baroffiomichele cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma
AT rovatigenrico cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma
AT crimiemanuele cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma
AT brusascovito cysteinylleukotrienesintheregulationofbsub2subadrenoceptorfunctionaninvitromodelofasthma